We are excited to announce that our Principal, Ms. Pauli Wong, has been appointed as the Honorary IP Advisor by the Hong Kong Medical & Healthcare Device Industries Association (HKMHDIA) for the term 2025-2026. She will provide advice and guidance to support HKMHDIA’s mission in advocating for streamlined regulatory policies to position Hong Kong as a leader in medical technologies. 

Pauli has served many HKMHDIA members in the life sciences and medical devices sectors as their patent attorney over the past few years. She is eager to provide strategic guidance for the association, leveraging her deep understanding of intellectual property to help HKMHDIA members safeguard their innovations and enhance their competitive edge. 

We are confident that Pauli's expertise and dedication will greatly benefit HKMHDIA and its members, driving innovation and success in the life sciences and medical devices sector of Hong Kong. 

Our Past Events

Jennifer Che has been Recognized in IAM Strategy 300 Global Leaders 2026

26 November 2025

Jennifer Che has been Recognized as IAM Global Leaders 2026

4 November 2025

Eagle IP is Coming to San Francisco and Washington DC!

15 October 2025

Jennifer Che has been listed on the IAM Strategy 300

15 August 2025

Eagle IP Recognized as Top Tier Firm (Tier 1) for Patent Prosecution in IP Stars 2025 Patent Firms Ranking List

3 July 2025

Dr. Jacqueline Lui, Ms. Pauli Wong, and Mr. Eddie Ho Named Patent Stars by ManagingIP

13 June 2025

Recommended Insights

Finally a unified “Court of Appeal” for technology IP in China

22 January 2019
On October 26, 2018, China’s Supreme People’s Court (“SPC”) received approval to establish a specialized intellectual property court within the SPC to handle appeal cases involving technology-related IP for both civil (e.g., patent infringement) and administrative (e.g., patent invalidity) judgments. Technology-related IP includes invention patents, utility models, new plant species, IC design, trade secret, software, […]
Read more >

CHINA: New Patent Examination Guidelines Now Available for Public Comment

4 August 2021
Two months after the new Chinese Patent law came into effect, the CNIPA has released a new set of Patent Examination Guidelines (proposed version) for public comments on Aug 3, 2021. Here are the explanation of the amendments (Chinese only). Here is the full set of proposed amendments (Chinese only). Briefly, the new amendment focuses […]
Read more >

First Ever Successful Invalidation Challenge Due to Unauthorized Foreign Filing

8 March 2023
What does an invention “completed” in China mean? China and the US are similar in that both countries highly value national security, and thus have rules regulating the exportation of technology and information from within their borders. This includes new inventions that arise from within their respective borders. As such, both governments require inventors who […]
Read more >

Narrow Claim Scope of a Chinese Utility Model Patent Fuels Design-Arounds by Failing to Curb Competing Products:

28 October 2020
Learning from a 2019 China’s Top 50 Representative IP Case The number of patent applications in China is now the highest in the world, with more than half the applications filed as utility model applications (UMs). For example, there were more than 2 million UMs filed in 2018 alone (for the difference between a utility […]
Read more >
Top crossarrow-right